New Topical PDE4 Inhibitor Gets FDA Green Light for Chronic Skin Disease
(MedPage Today) -- The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for ...
(MedPage Today) -- The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.